E

Encore Medical Research, LLC | Hollywood, FL

Research site
(Unclaimed)
Location
5555 Hollywood Boulevard Suite 101, Hollywood, Florida, United States of America
Site insights

Top conditions

Hidradenitis Suppurativa (1 trial)

Vitiligo (1 trial)

Atopic Dermatitis (1 trial)

Ulcerative Colitis (1 trial)

Hidradenitis (1 trial)

Top treatments

SAR444656
GS-1427
Upadacitinib
Obeldesivir

Parent organization

This site is a part of Encore Medical Research, LLC

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa (ZEN)

This is a parallel, Phase 2, 2-arm study to evaluate the efficacy, safety, PK, and biological effects of SAR444656 compared with placebo in adult par...

Enrolling
Hidradenitis Suppurativa
Drug: Placebo
Drug: SAR444656 (KT-474)

Vitiligo is a common chronic autoimmune disease that causes the body's immune system to attack its own pigment producing skin cells. This study is to...

Invitation-only
Vitiligo
Drug: Placebo
Drug: Upadacitinib

This is a multinational, multicenter, double-blind, placebo-controlled, parallel-group Phase 2, 3-arm study in adult participants with moderate to se...

Enrolling
Atopic Dermatitis
Drug: SAR444656 (KT-474)
Drug: Placebo
Locations recently updated

The goal of this study is to learn if GS-1427 is effective and safe in treating participants with moderate to severe ulcerative colitis. The study wi...

Enrolling
Ulcerative Colitis
Drug: Ustekinumab
Drug: GS-1427

Trial sponsors

Gilead Sciences logo

Gilead Sciences (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems